How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

Explore 100 Mandela Effects so strong you'll question your memory. From movie quotes to logos, discover collective false ...

Stocks slide as semiconductor selloff deepens on AI spending fears, valuations, oil tensions and key data ahead.

Oppenheimer says SpaceX/Tesla’s Terafab using Intel 18A is critical to SpaceX valuation—AI & space-hardened chips, $120B risk ...

Follow this tag to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings by Tiago Ventura by Chad de Guzman by Chad de Guzman by Callum Sutherland by ...

Cathie Wood's ARK Invest bought $2.1M of CoreWeave stock after a 30% crash. Here's why she's betting on the AI cloud company ...

Complexity is the property of a system whose behaviour as a whole emerges as distinct from the simple sum of its individual behaviours. The understanding of complex systems is therefore beyond the ...

This past summer has seen major updates in the burgeoning relationship between the U.S. government and developers of the ...